Risks Related to Patent and Trademark Protection and Infringement
First written in FY2016. 6 of 8 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2025: 9 of 59 companies on the "Worse" side.
- FY2025RestatedAnnual report
「As of the end of the consolidated fiscal year, the Company and its consolidated subsidiaries held more than 11,800 patents in Japan and more than 25,400 patents overseas. In addition, more than 4,700 patents were pending in Japan and more than 10,600 overseas.」
Continues to disclose risks relating to intellectual-property protection and infringement and updates the numbers of patents held and applications filed. - FY2024RestatedAnnual report
「As of the end of the consolidated fiscal year, the Company and its consolidated subsidiaries held more than 13,100 patents in Japan and more than 26,600 patents overseas. In addition, more than 4,800 patents were pending in Japan and more than 11,900 overseas.」
Continues to disclose risks relating to intellectual-property protection and infringement and updates the numbers of patents held and applications filed. - FY2023RestatedAnnual report
「As of the end of the consolidated fiscal year, the Company and its consolidated subsidiaries held more than 15,000 patents in Japan and more than 27,100 patents overseas. In addition, more than 5,800 patents were pending in Japan and more than 14,200 overseas.」
Continues to disclose risks relating to intellectual-property protection and infringement and updates the numbers of patents held and applications filed. - FY2020ReframedAnnual report
「The Group's business and results of operations may be adversely affected if its intellectual property cannot be protected broadly, if its intellectual property rights are infringed unlawfully on a broad scale, or if patent-infringement lawsuits result in injunctions against manufacturing or sales, substantial damages or claims for licence fees.」
Specifies insufficient protection of or infringement involving patents and trademarks, as well as injunctions against manufacturing and sales, substantial damages and claims for licence fees arising from patent-infringement lawsuits. - FY2019RestatedAnnual report
「As of the end of the consolidated fiscal year, the Company and its consolidated subsidiaries held more than 21,600 patents in Japan and more than 28,000 patents overseas. In addition, more than 6,800 patents were pending in Japan and more than 14,300 overseas.」
Continues to disclose intellectual-property risks and updates the numbers of patents held and applications filed. - FY2018RestatedAnnual report
「As of the end of the consolidated fiscal year, the Company and its consolidated subsidiaries held more than 21,300 patents in Japan and more than 27,200 patents overseas. In addition, more than 6,300 patents were pending in Japan and more than 14,200 overseas.」
Updates patent holdings to more than 21,300 in Japan and more than 27,200 overseas, and pending applications to more than 6,300 in Japan and more than 14,200 overseas. - FY2017RestatedAnnual report
「As of the end of the consolidated fiscal year, the Company and its consolidated subsidiaries held more than 20,500 patents in Japan and more than 26,100 patents overseas.」
Reconfirms the importance of intellectual property protection and discloses holdings of more than 20,500 patents in Japan and more than 26,100 overseas. - FY2016First statedAnnual report
「The Group's business activities may be adversely affected if this intellectual property cannot be protected broadly or if the Group's intellectual property rights are infringed unlawfully on a broad scale.」
Identifies both insufficient protection of intellectual property and infringement by third parties as risks.